ReviewCurrent atherosclerosis reports2021

The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently?

Marcio H Miname et al.PubMed ↗Publisher ↗

No numbers read from the abstract.